Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer.
Li J, Alyamani M, Zhang A, Chang KH, Berk M, Li Z, Zhu Z, Petro M, Magi-Galluzzi C, Taplin ME, Garcia JA, Courtney K, Klein EA, Sharifi N.
Li J, et al. Among authors: klein ea.
Elife. 2017 Feb 13;6:e20183. doi: 10.7554/eLife.20183.
Elife. 2017.
PMID: 28191869
Free PMC article.